Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical practice: comment on «Variability of denosumab densitometric response in postmenopausal osteoporosis.

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical...
Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Gebro
Faes Farma
Meiji Pharma